Innovative Gene Therapy Approaches For Treatment Of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory illness that primarily involves the joints but can also have systemic repercussions, affecting numerous organs and systems throughout the body. It is classified as an autoimmune disease, in which the immune system mistakenly targets healthy joint tissues, causing inflammation, pain, and eventual damage to the joints. Traditional therapeutic approaches for rheumatoid arthritis (RA) have predominantly aimed at symptom management and the application of disease-modifying antirheumatic drugs (DMARDs). However, these approaches frequently exhibit limited effectiveness and can lead to substantial side effects. In response to these challenges, innovative gene therapy strategies have emerged, providing a promising new frontier for targeted molecular intervention in the treatment of RA. The possible advantages of these therapeutic modalities consist of lower systemic toxicity, enhanced targeting of pathological pathways, and the opportunity for long-term remission through genetic modifications. The integration of gene therapy into the management of rheumatoid arthritis (RA) holds promise for improved patient outcomes and a shift towards more personalized healthcare. This article reviews recent innovations in gene therapy strategies aimed at modulating immune responses and fostering tissue regeneration in affected joints.